Stock Analysis
Viatris Inc. (VTRS) Stock Analysis
Viatris Inc. (VTRS) stock analysis covering valuation, fundamentals, technical indicators, risk, AIQ Momentum, analyst catalysts, dividends, and the current AIQ Score.
Viatris Inc. (VTRS) currently has an AIQ Score of 54/100, indicating a neutral setup. Value is the strongest factor at 73/100. Quality is the weakest current factor at 31/100. Technical, fundamental, catalyst, dividend, and risk evidence should be read together at the latest market-close snapshot.
VTRS at a Glance
Crawlable current metrics from the latest market-close stock snapshot.
| Metric | Current |
|---|---|
| Price | $16.51 |
| AIQ Score | 54/100 |
| Overall View | Neutral |
| Technical Analysis Consensus | Sell |
| Market Cap | $19.37B |
| P/E Ratio | 6.6 |
| Forward P/E | — |
| EPS | -$0.10 |
| Revenue TTM | $3.76B |
| Dividend Yield | 0.01% |
| Beta | 0.89 |
| Volume | 12.18M |
| 52-week range | $9.43-$18.39 |
| RSI 14 | 53.51 |
| 50-Day SMA | $16.79 |
| 200-Day SMA | $14.84 |
| Analyst Price Target | $21.00 |
| Next Earnings | Nov 5, 2026 |
Create a free account to keep researching stocks
You have viewed 2 stock pages in the last 24 hours. Create a free account to keep researching current evidence.
VTRS
OverviewVTRS Stock Analysis Summary
Viatris Inc. (VTRS) currently has an AIQ Score of 54/100, indicating a neutral setup. Value is the strongest factor at 73/100. Quality is the weakest current factor at 31/100. Technical, fundamental, catalyst, dividend, and risk evidence should be read together at the latest market-close snapshot.
In a neutral regime, VTRS has AIQ Score of 54/100 with Value base of 73/100 and fading Quality at 31/100. Wait for component alignment before adding exposure.
Value (73/100) leads while Quality (31/100) lags. This cross-factor spread creates entry timing uncertainty.
Healthcare · 0.79% stock move · VTRS classified in Drug Manufacturers - Specialty & Generic.
Current Evidence
AlgovestIQ Evidence Summary
Current consensus, supporting evidence, recent changes, and what would strengthen or weaken the view.
Is VTRS Bullish or Bearish Right Now?
VTRS currently has a neutral overall setup. Value is the strongest factor at 73/100, while Quality is weakest at 31/100. The current evidence suggests a mixed rather than strongly bullish or bearish setup.
- - Risk Resilience is supportive at 64/100.
- - Analyst target implies +27.20% upside from the latest quote.
- - Technical consensus has more sell votes than buy votes (27 vs 9).
Current Consensus
VTRS's Technical Analysis Consensus is currently Sell, with 9 buy, 9 neutral, and 27 sell votes. VTRS's 14-day RSI is 53.51, which places the stock in a neutral momentum range. VTRS's beta is 0.89, indicating market sensitivity broadly in line with the market.
What Changed in VTRS?
Recent score-change history is not available in the current snapshot. These are the latest market-close scores instead.
What Would Change the VTRS Outlook?
The current neutral outlook could improve if AIQ moves above 70, momentum recovers, earnings revisions strengthen, and price confirms a stronger trend above the 50-day and 200-day moving averages. It would weaken if AIQ falls below 40, price loses long-term moving-average support, analyst expectations deteriorate, or risk evidence worsens.
AIQ > 70, RSI above 55, price above SMA-50/SMA-200, and positive catalyst or estimate-revision evidence.
AIQ below 40, RSI below 45, loss of SMA-200, negative revisions, or rising volatility and drawdown risk.
VTRS Decision Framework
Public evidence layers, setup checks, and risk context for Viatris Inc..
Viatris Inc. (VTRS) Stock Analysis
Viatris Inc. has an AIQ Score of 54/100 in a Neutral regime. Value is strongest at 73/100. Beta is 0.89, below market sensitivity. Review the supporting stock factors together before drawing a conclusion from any single score.
| Evidence Layer | Public Evidence |
|---|---|
| Regime Context | VTRS is in a Neutral AIQ regime with score 54/100. |
| Signal Conflict | The primary conflict is that value leads at 73/100 while quality lags at 31/100. |
| Factor Evidence | Momentum 51/100 · Value 73/100 · Quality 31/100 · Risk 64/100 |
| Persistence | Current snapshot evidence is shown; historical persistence remains in AIQ Pro. |
Current Setup Checklist
Value is the strongest factor at 73/100.
Momentum is 51/100 and RSI (14) is 53.5.
VTRS is in a Neutral regime at 54/100.
Risk factor is 64/100 with beta 0.89 and annual volatility 32.17%.
Current conflict: value leads at 73/100 while quality lags at 31/100.
VTRS Research Cluster
Ticker-specific paths for valuation, technical analysis, catalysts, dividends, financials, risk, and news.
VTRS Fundamentals
VTRS valuation, profitability, growth, margins, balance-sheet strength, and free cash flow.
VTRS Technical Analysis
VTRS technical setup based on RSI, MACD, moving averages, AIQ Momentum, volume, trend, volatility, and pivots.
VTRS Stock Catalysts
Track VTRS earnings, analyst ratings, price targets, estimate revisions, stock news, and upcoming events.
VTRS Dividend Analysis
VTRS dividend yield, annual dividend, payout ratio, payment history, and income reliability context.
VTRS Financial Data
VTRS revenue, earnings, income statement, balance sheet, cash flow, valuation ratios, and stock metrics.
VTRS Risk Analysis
VTRS volatility, beta, drawdown, Sharpe ratio, VaR, and downside resilience.
VTRS Stock News
VTRS stock news, market tone, recent headlines, and catalyst context.
VTRS vs Medical Devices Peers
Current peer cohort: VTRS · WAT · XRAY · ZBH · ABT. Compare AIQ, factor scores, Sharpe ratio and 1-year volatility in one indexable view.
| Peer | AIQ | Value | Momentum | Risk | Sharpe | 1Y Volatility | Compare |
|---|---|---|---|---|---|---|---|
| VTRS Current stock | 54/100 | 73/100 | 51/100 | 64/100 | 1.53 | 32.17% | Current |
| WAT Waters Corporation | 47/100 | 32/100 | 52/100 | 65/100 | 1 | 36.07% | VTRS vs WAT |
| XRAY Dentsply Sirona | 46/100 | 73/100 | 34/100 | 51/100 | -0.44 | 46.33% | VTRS vs XRAY |
| ZBH Zimmer Biomet | 52/100 | 67/100 | 28/100 | 54/100 | -0.24 | 31.98% | VTRS vs ZBH |
| ABT Abbott Laboratories | 45/100 | 48/100 | 20/100 | 57/100 | -0.9 | 27.02% | VTRS vs ABT |
Peer cohort is resolved dynamically from the AlgovestIQ universe taxonomy and Compare relationship graph. Data as of Sep 11, 2026.
About the AIQ Score
Methodology for the current stock evidence.
The AlgovestIQ AIQ Score combines multiple dimensions of stock evidence, including momentum, valuation exposure, quality, risk resilience, sentiment context, and timing signals. It is a descriptive research score, not a guarantee of future performance or a personalized recommendation.
View AIQ methodologyFactor Diagnostics
A compact bridge from the AIQ score to the evidence tabs.
Open the return calculator with stock context while purchase price, shares, dates and fees remain user inputs.
AIQ Component Profile
Compare the five component scores on one consistent 0–100 scale.
Review earnings timing, revisions, news pressure, and prior event reactions in one place.
Open catalysts6 recent quarterly periods are available for review.
Checked Sep 12, 2026
Explore factor drivers, conflicts, persistence, and scenario sensitivity in the advanced workspace.
Fundamentals Verdict
Current snapshot fields are separate from reported-quarter statement tables.
Latest period Jun 30, 2026.
Market Confirmation
Technicals are summarized first, with the indicator library behind it.
Risk Alignment
Higher resilience is stronger; exposure metrics stay separate.
Continue Researching VTRS
Open the detailed evidence pages and workflows behind the stock overview read.
Premium Feature
Full AIQ Analysis
AIQ Intelligence
AIQ Pro for VTRS
Scenario Analysis
AIQ Scenario Builder
Portfolio Implication
Related Links
VTRS Stock FAQ
What is VTRS stock price today?
Viatris Inc.'s current stock price is $16.51. Use the live quote with AIQ Score, news, and risk context rather than treating price alone as a decision signal.
Is VTRS bullish or bearish right now?
VTRS's bullish or bearish read depends on the current AIQ Score, factor alignment, technical analysis consensus, valuation, risk, and catalyst evidence. A mixed setup should be treated differently from a broad confirmation across those signals.
What is VTRS's market cap?
VTRS's market cap is $19.37B based on the latest completed market-close snapshot from Sep 11, 2026. Use it with P/E ratio, revenue, and growth metrics to frame company size, valuation, and peer comparisons.
What is VTRS's current P/E ratio?
VTRS's current P/E ratio is 6.6 based on the latest completed market-close snapshot from Sep 11, 2026. Read it with revenue growth, margins, EPS, cash flow, and peer valuation rather than using P/E alone.
What is VTRS's RSI?
VTRS's 14-day RSI is 53.51 based on the latest completed market-close snapshot from Sep 11, 2026. RSI should be interpreted with MACD, moving averages, volume, volatility, and price trend.
Is VTRS above its 50-day and 200-day moving averages?
VTRS is -1.68% from its 50-day SMA and 11.23% from its 200-day SMA based on the latest completed market-close snapshot from Sep 11, 2026. Moving-average position should be read with momentum and broader AIQ evidence.
When is VTRS's next earnings date?
VTRS's next earnings date is currently listed as Nov 5, 2026. Earnings can reset revenue, EPS, price target, analyst rating, and catalyst expectations.
Does VTRS pay a dividend?
VTRS's dividend yield is 0.01% based on the latest completed market-close snapshot from Sep 11, 2026. Dividend yield should be read with payout ratio, free cash flow, growth, and balance-sheet strength.